{
    "2019-01-27": [
        [
            {
                "time": "2018-01-27",
                "original_text": "利妥昔首仿将上市，国内生物类似药进度盘点【周观点|长江医药0127】",
                "features": {
                    "keywords": [
                        "利妥昔",
                        "首仿",
                        "上市",
                        "生物类似药",
                        "进度",
                        "长江医药"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-27",
                "original_text": "康美中医药全产业链动了谁的奶酪？",
                "features": {
                    "keywords": [
                        "康美",
                        "中医药",
                        "全产业链",
                        "奶酪"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}